Spyre Therapeutics, Inc. - SYRE

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 26
Latest filed: Apr 03, 2026
Form Count
4 14
8-K 5
144 4
SCHEDULE 13G/A 2
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Apr 03, 2026 4 Apr 01, 2026 0001853327-26-000003 View
Apr 03, 2026 4 Apr 01, 2026 0001636282-26-000030 View
Apr 03, 2026 4 Apr 01, 2026 0001758363-26-000007 View
Apr 01, 2026 144 0001950047-26-003140 View
Mar 27, 2026 SCHEDULE 13G/A 0000102909-26-002337 View
Mar 03, 2026 4 Mar 02, 2026 0001636282-26-000026 View
Mar 03, 2026 4 Mar 03, 2026 0001636282-26-000028 View
Mar 03, 2026 144 0001950047-26-002111 View
Mar 02, 2026 144 0001950047-26-001983 View
Feb 19, 2026 8-K Feb 19, 2026 0001636282-26-000022 View
Feb 17, 2026 SCHEDULE 13G/A 0001214659-26-002024 View
Feb 04, 2026 4 Feb 02, 2026 0001758363-26-000005 View
Jan 23, 2026 4 Jan 21, 2026 0001779990-26-000002 View
Jan 13, 2026 4 Jan 09, 2026 0001636282-26-000001 View
Jan 13, 2026 4 Jan 09, 2026 0001636282-26-000002 View
Jan 13, 2026 4 Jan 09, 2026 0001636282-26-000003 View
Jan 13, 2026 4 Jan 09, 2026 0001636282-26-000004 View
Jan 12, 2026 8-K Jan 12, 2026 0001193125-26-009894 View
Jan 06, 2026 4 Jan 02, 2026 0001758363-26-000002 View
Dec 03, 2025 4 Dec 01, 2025 0001758363-25-000003 View
Nov 05, 2025 4 Nov 03, 2025 0001636282-25-000106 View
Nov 04, 2025 8-K Nov 04, 2025 0001636282-25-000104 View
Nov 03, 2025 144 0001950047-25-008390 View
Oct 17, 2025 SCHEDULE 13D/A 0001104659-25-100449 View
Oct 15, 2025 8-K Oct 13, 2025 0001193125-25-240237 View
Oct 14, 2025 8-K Oct 14, 2025 0001193125-25-237904 View